Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL. Blombery P, Lew TE, Dengler MA, Thompson ER, et al. Blood 2022;139:1198-1207.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Blombery P, Lew TE, Dengler MA, Thompson ER, et al. Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL. Blood 2022;139:1198-1207.
PMID: 34469514